| Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests IV Belozertseva, T Kos, P Popik, W Danysz, AY Bespalov European neuropsychopharmacology 17 (3), 172-179, 2007 | 225 | 2007 |
| Glutamatergic (N-methyl-D-aspartate receptor) hypofrontality in schizophrenia: too little juice or a miswired brain? GJ Marek, B Behl, AY Bespalov, G Gross, Y Lee, H Schoemaker Molecular pharmacology 77 (3), 317-326, 2010 | 189 | 2010 |
| Naltrexone for heroin dependence treatment in St. Petersburg, Russia EM Krupitsky, EE Zvartau, DV Masalov, MV Tsoi, AM Burakov, ... Journal of substance abuse treatment 26 (4), 285-294, 2004 | 152 | 2004 |
| Generation and therapeutic efficacy of highly oligomer-specific β-amyloid antibodies H Hillen, S Barghorn, A Striebinger, B Labkovsky, R Müller, V Nimmrich, ... Journal of Neuroscience 30 (31), 10369-10379, 2010 | 150 | 2010 |
| Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue-and schedule-induced reinstatement of nicotine self-administration behavior in rats AY Bespalov, OA Dravolina, I Sukhanov, E Zakharova, E Blokhina, ... Neuropharmacology 49, 167-178, 2005 | 150 | 2005 |
| Effect of memantine on cue-induced alcohol craving in recovering alcohol-dependent patients EM Krupitsky, O Neznanova, D Masalov, AM Burakov, T Didenko, ... American Journal of Psychiatry 164 (3), 519-523, 2007 | 130 | 2007 |
| Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia EM Krupitsky, EE Zvartau, DV Masalov, MV Tsoy, AM Burakov, ... Journal of substance abuse treatment 31 (4), 319-328, 2006 | 129 | 2006 |
| Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats M Pietraszek, I Sukhanov, P Maciejak, J Szyndler, A Gravius, A Wisłowska, ... European journal of pharmacology 514 (1), 25-34, 2005 | 124 | 2005 |
| Stimulation of the metabotropic glutamate 2/3 receptor attenuates social novelty discrimination deficits induced by neonatal phencyclidine treatment S Harich, G Gross, A Bespalov Psychopharmacology 192, 511-519, 2007 | 117 | 2007 |
| Improving transparency and scientific rigor in academic publishing EM Prager, KE Chambers, JL Plotkin, DL McArthur, AE Bandrowski, ... Journal of neuroscience research 97 (4), 377-390, 2019 | 105 | 2019 |
| Improving target assessment in biomedical research: the GOT-IT recommendations CH Emmerich, LM Gamboa, MCJ Hofmann, M Bonin-Andresen, O Arbach, ... Nature reviews Drug discovery 20 (1), 64-81, 2021 | 104 | 2021 |
| mGlu1 receptor blockade attenuates cue-and nicotine-induced reinstatement of extinguished nicotine self-administration behavior in rats OA Dravolina, ES Zakharova, EV Shekunova, EE Zvartau, W Danysz, ... Neuropharmacology 52 (2), 263-269, 2007 | 103 | 2007 |
| Effect of 5-HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and mice T Kos, P Popik, M Pietraszek, D Schäfer, W Danysz, O Dravolina, ... European Neuropsychopharmacology 16 (4), 297-310, 2006 | 102 | 2006 |
| Effects of nicotinic and NMDA receptor channel blockers on intravenous cocaine and nicotine self-administration in mice EA Blokhina, VA Kashkin, EE Zvartau, W Danysz, AY Bespalov European Neuropsychopharmacology 15 (2), 219-225, 2005 | 95 | 2005 |
| Behavioral characterization of the mGlu group II/III receptor antagonist, LY-341495, in animal models of anxiety and depression AY Bespalov, MM van Gaalen, IA Sukhotina, K Wicke, M Mezler, ... European journal of pharmacology 592 (1-3), 96-102, 2008 | 79 | 2008 |
| Effects of a positive allosteric modulator of group II metabotropic glutamate receptors, LY487379, on cognitive flexibility and impulsive-like responding in rats A Nikiforuk, P Popik, KU Drescher, M van Gaalen, AL Relo, M Mezler, ... Journal of Pharmacology and Experimental Therapeutics 335 (3), 665-673, 2010 | 77 | 2010 |
| Excitatory amino acid receptor antagonist kynurenic acid attenuates rewarding potential of morphine A Bespalov, M Dumpis, L Piotrovsky, E Zvartau European journal of pharmacology 264 (3), 233-239, 1994 | 74 | 1994 |
| Effects of abused drugs on thresholds and breaking points of intracranial self-stimulation in rats A Bespalov, A Lebedev, G Panchenko, E Zvartau European Neuropsychopharmacology 9 (5), 377-383, 1999 | 72 | 1999 |
| Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets A Bespalov, T Steckler, B Altevogt, E Koustova, P Skolnick, D Deaver, ... Nature Reviews Drug Discovery 15 (7), 516-516, 2016 | 71 | 2016 |
| Intravenous self-administration of abused solvents and anesthetics in mice EA Blokhina, OA Dravolina, AY Bespalov, RL Balster, EE Zvartau European journal of pharmacology 485 (1-3), 211-218, 2004 | 66 | 2004 |
